With the help of a chemical, diabetes sufferers with early symptoms could be prevented from developing the disease completely, research has suggested. Trials found that a specific peptide -- a substance formed from amino acids -- halted the progression of Type1 diabetes (the insulin-dependent form that must be treated with injections) in humans and mice. Jerusalem-based Hadassah-Hebrew University Medical School and Peptor Limited, a pharmaceutical company also based in Israel, conducted the research. It is hoped that the discovery could lead to the development of new life-saving drugs (www.thescotsman.co.uk, November 30, 2001).
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.